Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms (2019)
Source: Scientific Reports. Unidades: ICB, FMRP
Subjects: FARMACOLOGIA, DOENÇAS DA MEDULA ÓSSEA, TRANSTORNOS MIELOPROLIFERATIVOS, ANTINEOPLÁSICOS, EXPRESSÃO GÊNICA, CITOESQUELETO, DANO AO DNA, PROLIFERAÇÃO CELULAR, APOPTOSE
ABNT
LIMA, Keli Cristina de et al. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms. Scientific Reports, v. 9, p. 9 , 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-46163-2. Acesso em: 02 out. 2024.APA
Lima, K. C. de, Carlos, J. A. E. G., Paiva, R. de M. A., Vicari, H. P., Santos, F. P. de S., Hamerschlak, N., et al. (2019). Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms. Scientific Reports, 9, 9 . doi:10.1038/s41598-019-46163-2NLM
Lima KC de, Carlos JAEG, Paiva R de MA, Vicari HP, Santos FP de S, Hamerschlak N, Costa-Lotufo LV, Traina F, Machado Neto JA. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Scientific Reports. 2019 ; 9 9 .[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41598-019-46163-2Vancouver
Lima KC de, Carlos JAEG, Paiva R de MA, Vicari HP, Santos FP de S, Hamerschlak N, Costa-Lotufo LV, Traina F, Machado Neto JA. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Scientific Reports. 2019 ; 9 9 .[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41598-019-46163-2